The Role of PD-1 and PD-L1
Julie R. Brahmer, MD, explains the role of the PD-1 pathway and the ligands PD-L1 and PD-L2 in the regulation of the immune system.
Julie R. Brahmer, MD, from Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, explains the role of the PD-1 pathway and the ligands PD-L1 and PD-L2 in the regulation of the immune system.
Clinical Pearls
- The program death 1 (PD-1) pathway is a checkpoint pathway that controls immune response in the body to prevent extreme inflammation or other problems during illness
- PD-1 is a receptor on a T cell while its ligand, PD-L1, is expressed on peripheral tissues or tumor cells. PD-L2, another ligand, is also thought to be present on antigen-presenting cells or tumor cells, though research is ongoing
- When the T cell binds to one of its ligands, it deactivates the T cell. This protects the tumor from the body’s immune system
- When that response is blocked, the T cell can remain active and kill the tumor
Advancing Neoadjuvant Therapy for HER2+ Breast Cancer Through ctDNA Monitoring
December 19th 2024In an interview with Targeted Oncology, Adrienne Waks, MD, provided insights into the significance of the findings from the DAPHNe trial and their clinical implications for patients with HER2-positive breast cancer.
Read More
Systemic Therapy Choice Linked to Radiosurgery Outcomes in Brain Mets
December 6th 2024In an interview with Targeted OncologyT, Rupesh Kotecha, MD, discussed a study focused on how systemic therapy selection impacts outcomes in patients with brain metastases, particularly those with lung cancer.
Read More
